Brief: CytomX Therapeutics posts Q2 EPS USD -0.02
08/08/2023 22:39
Aug 8 (Reuters) - CytomX Therapeutics Inc. Q2 EPS USD -0.02. * Q2 revenue USD 24.724 million * Q2 cash & investments USD 180.9 million
Recent news on CytomX Therapeutics
See all newsCytomX Q2 revenue misses, partly hurt by lower research activities in the Astellas collaboration
CytomX Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Cytomx Therapeutics Announces Appointment Of Charles Fuchs, M.D., M.P.H., To The Board Of Directors
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway